Cuiling Zeng

768 total citations
13 papers, 527 citations indexed

About

Cuiling Zeng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Cuiling Zeng has authored 13 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Cuiling Zeng's work include RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and RNA Research and Splicing (4 papers). Cuiling Zeng is often cited by papers focused on RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and RNA Research and Splicing (4 papers). Cuiling Zeng collaborates with scholars based in China, Hong Kong and United States. Cuiling Zeng's co-authors include Li Zhong, Tiebang Kang, Ruhua Zhang, Dan Liao, Xinchun Li, Meifang Zhang, Haiqing Ma, Xin Wang, Wenqiang Liu and Jianhua Sui and has published in prestigious journals such as Nature Cell Biology, Oncogene and Scientific Reports.

In The Last Decade

Cuiling Zeng

13 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuiling Zeng China 9 443 280 76 69 48 13 527
Shaorui Gu China 10 425 1.0× 271 1.0× 84 1.1× 66 1.0× 55 1.1× 16 527
Qiou Gu China 9 521 1.2× 380 1.4× 94 1.2× 60 0.9× 22 0.5× 10 603
Dejun Wu China 12 323 0.7× 213 0.8× 98 1.3× 90 1.3× 50 1.0× 19 467
Zuoming Xu China 12 387 0.9× 313 1.1× 59 0.8× 53 0.8× 73 1.5× 20 486
Jia Xiong China 6 435 1.0× 273 1.0× 94 1.2× 46 0.7× 103 2.1× 8 588
Yuanfei Shi China 11 375 0.8× 160 0.6× 97 1.3× 30 0.4× 38 0.8× 26 488
Xiaozhi Lv China 12 387 0.9× 276 1.0× 97 1.3× 66 1.0× 26 0.5× 38 515
Shubiao Ye China 11 237 0.5× 133 0.5× 119 1.6× 39 0.6× 55 1.1× 26 402

Countries citing papers authored by Cuiling Zeng

Since Specialization
Citations

This map shows the geographic impact of Cuiling Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuiling Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuiling Zeng more than expected).

Fields of papers citing papers by Cuiling Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuiling Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuiling Zeng. The network helps show where Cuiling Zeng may publish in the future.

Co-authorship network of co-authors of Cuiling Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Cuiling Zeng. A scholar is included among the top collaborators of Cuiling Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuiling Zeng. Cuiling Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhou, Liwen, Ting Li, Ruhua Zhang, et al.. (2024). Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer. Advanced Science. 11(22). e2310146–e2310146. 11 indexed citations
2.
Zheng, Lisi, Jingxuan Wang, Shan Han, et al.. (2024). The KLF16/MYC feedback loop is a therapeutic target in bladder cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 303–303. 1 indexed citations
3.
Wang, Jingxuan, Lisi Zheng, Xia Zhang, et al.. (2024). Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin. Oncogene. 44(9). 575–586. 1 indexed citations
4.
Zhong, Li, Jingxuan Wang, Dongming Lv, et al.. (2023). Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma. Science Advances. 9(47). eadi0889–eadi0889. 15 indexed citations
5.
Zeng, Cuiling, Li Zhong, Wenqiang Liu, et al.. (2022). Targeting the Lysosomal Degradation of Rab22a‐NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis. Advanced Science. 10(5). e2205483–e2205483. 28 indexed citations
6.
Zhong, Li, Dan Liao, Jingjing Li, et al.. (2021). Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes. Signal Transduction and Targeted Therapy. 6(1). 59–59. 73 indexed citations
7.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 868–881. 47 indexed citations
8.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 907–907. 1 indexed citations
9.
Zhong, Li, Dan Liao, Meifang Zhang, et al.. (2018). YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma. Cancer Letters. 442. 252–261. 282 indexed citations
10.
Qi, Cuiling, Bin Li, Yang Yang, et al.. (2016). Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis. Scientific Reports. 6(1). 27819–27819. 25 indexed citations
11.
Zheng, Lingyun, Teng Wu, Cuiling Zeng, et al.. (2015). SAP deficiency mitigated atherosclerotic lesions in ApoE−/− mice. Atherosclerosis. 244. 179–187. 21 indexed citations
12.
Zheng, Lingyun, Cuiling Zeng, Teng Wu, et al.. (2014). Inactivation of PI3Kδ Induces Vascular Injury and Promotes Aneurysm Development by Upregulating the AP-1/MMP-12 Pathway in Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 35(2). 368–377. 16 indexed citations
13.
Zeng, Cuiling, et al.. (1995). Effects of antisense epidermal growth factor and its receptor retroviral expression vectors on cell growth of human pancreatic carcinoma cell line.. PubMed. 108(9). 653–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026